XML 25 R25.htm IDEA: XBRL DOCUMENT v3.19.3
Supplemental Disclosure of Cash Flow Information
12 Months Ended
Dec. 31, 2018
Supplemental Cash Flow Elements [Abstract]  
Supplemental Disclosure of Cash Flow Information

Note 19 – Supplemental Disclosure of Cash Flow Information

 

   Year Ended December 31, 
   2018   2017 
Cash paid for interest  $313,918    $1,200,759 
Cash paid for income taxes  $23,362    $541,313 
           
Acquisition of Jamestown Regional Medical Center:          
Inventory  $450,682   $- 
Prepaid and other assets   310,385    - 
Property and equipment   7,129,484    - 
Intangible assets   504,806    - 
Accrued expenses   (193,966)   - 
           
Non-cash investing and financing activities:          
Cashless exercise of warrants   4,619,150    - 
Exchange of debentures for Series I-2 Preferred Stock   3,127,556    - 
Note payable and accrued expenses settled through issuance of Series J Preferred Stock   250,000    - 
Common stock issued for conversion of Series I-2 Preferred Stock   1,513,105    - 
Beneficial conversion feature   

192,308

      
Services and severance settled through the issuances of common stock   -    161,003 
Exchange of convertible debentures for convertible debentures and warrants   -    10,734,336 
Series F Preferred Stock issued for business acquisition   -    174,097 
Notes payable and warrants settled through issuance of common stock   -    440,000 
Convertible debentures issued in exchange for Series H Preferred Stock   -    2,695,760 
Debentures converted into common stock   8,128,044    7,306,314 
Deemed dividend for trigger of down round provision feature   231,843,826    53,341,619 
Conversions of preferred stock into common stock   -    7,785,000 
Value of convertible liabilities   -    12,435,250